Building the infrastructure layerfor tech-enabled drug discovery
We are the only biotechnology company advancing small and large molecule drug discovery with a multimodal AI platform powered by laboratory automation.
We integrate AI with three proprietary data streams – computational data, wet lab proxy biological data, and wet lab ground truth biological data – to deliver novel drug candidates and software solutions to leading pharma and tech partners, and advance our internal pipeline for neurological, autoimmune diseases, and cancer.
Want more insights? Check out our posts.
Have a lookThis Biotech Founder Wants to Use AI to Help Get Drugs to Market Faster
7m read 21st March, 2024.
Microsoft and 1910 Genetics Partner to Build the Infrastructure Layer for Drug Discovery and Development Using AI and High-Performance Computing
6m read 29th February, 2024.
JP Morgan 2024 – Jen Nwankwo
0m read 29th January, 2024.